MORGANTOWN, W. Va., Feb. 02, 2016 -- Protea Biosciences Group, Inc., (OTCQB:PRGB) announced that the Company will be presenting at the BIO CEO & Investor Conference taking place on February 8-9, 2016 at the Waldorf Astoria Hotel in New York City. Stephen Turner, Chairman and CEO, will present at 8:30 am ET on Monday, February 8, 2016.
To listen to the live audio webcast of the presentation during the event, please visit:
http://www.veracast.com/webcasts/bio/ceoinvestor2016/34103292263.cfm
A replay of the webcast will be available for 90 days after the initial presentation.
Management will be available for one-on-one meetings with conference attendees. Meetings can be arranged through the conference's partnering system at http://www.bio.org/events/conferences/bio-ceo-investor-conference or by contacting the Company at [email protected].
About Protea Biosciences
Protea Biosciences Group, Inc. (OTCQB:PRGB) is a molecular information company providing innovative bio-analytical technology to the pharmaceutical and life science industries. "Molecular information" refers to the generation and bioinformatic processing of very large data sets, obtained by applying the Company's proprietary technology to identify and characterize the proteins, metabolites, lipids and other biomolecules which are the byproducts of all living cells and life forms.
For more Information:
Protea Biosciences Group, Inc., 1311 Pineview Dr., Morgantown, WV 26505 USA
Phone: 304.292.2226 Fax: 304.606.3049
https://proteabio.com/investors
Protea is a registered trademark of Protea Biosciences Group, Inc.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



